TRANSIENT MYOPIA WITH SEVERE CHEMOSIS ASSOCIATED WITH EXACERBATION OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
SHU, U
TAKEUCHI, F
TANIMOTO, K
MOROI, Y
UCHIDA, KI
ITO, K
机构
[1] UNIV TOKYO,SCH MED,DEPT OPHTHALMOL,TOKYO 113,JAPAN
[2] NATL HOSP ITOH SPA,SHIZUOKA,JAPAN
关键词
TRANSIENT MYOPIA; SEVERE CHEMOSIS; SLE; DISEASE ACTIVITY; SYSTEMIC EDEMA AND FUNDAL CHANGE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 46-year-old woman with systemic lupus erythematosus (SLE) developed bilateral transient myopia and periorbital edema with severe chemosis. Her myopia was ascribed to a refractive abnormality that was caused by curvature change and anterior displacement of the lenses and the ciliary bodies due to anterior ocular edema. The conditions were not associated with systemic edema or abnormality in the fundi and responded well to the systemic administration of corticosteroid. The course of the ocular symptoms paralleled changes of serum CH50 and anti-dsDNA antibody levels. Thus it was concluded that her ocular symptoms were closely related to activity of her SLE and may be considered a feature of SLE.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 50 条
  • [1] FIBROMYALGIA SYNDROME AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    MORAND, EF
    MILLER, MH
    WHITTINGHAM, S
    LITTLEJOHN, GO
    LUPUS, 1994, 3 (03) : 187 - 191
  • [2] HYPERPROLACTINEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH DISEASE-ACTIVITY
    JARA, LJ
    GOMEZSANCHEZ, C
    SILVEIRA, LH
    MARTINEZOSUNA, P
    VASEY, FB
    ESPINOZA, LR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (04): : 222 - 226
  • [3] RETINOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATIONSHIP TO DISEASE-ACTIVITY
    KLINKHOFF, AV
    BEATTIE, CW
    CHALMERS, A
    ARTHRITIS AND RHEUMATISM, 1986, 29 (09): : 1152 - 1156
  • [4] SEROLOGICAL MARKERS OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SPRONK, PE
    LIMBURG, PC
    KALLENBERG, CGM
    LUPUS, 1995, 4 (02) : 86 - 94
  • [5] CRITERIA FOR ASSESSING DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ISENBERG, D
    BACON, P
    BOMBARDIER, C
    GLADMAN, D
    GOLDSMITH, CH
    KALUNIAN, K
    LIANG, M
    MADDISON, P
    NIVED, O
    RICHTER, M
    SNAITH, M
    SYMMONS, D
    UROWITZ, M
    ZOMA, A
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (10) : 1395 - 1396
  • [6] TRANSIENT HIGH MYOPIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS ASSOCIATED WITH ANASARCA
    AYAZI, S
    ARMSTRONG, WL
    WEINSTEIN, A
    ANNALS OF OPHTHALMOLOGY, 1982, 14 (08): : 785 - 787
  • [7] PROLACTIN - A STIMULATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    WALKER, SE
    ALLEN, SH
    HOFFMAN, RW
    MCMURRAY, RW
    LUPUS, 1995, 4 (01) : 3 - 9
  • [8] THE LUPUS BAND TEST AS A MEASURE OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    HALBERG, P
    ULLMAN, S
    JORGENSEN, F
    ARCHIVES OF DERMATOLOGY, 1982, 118 (08) : 572 - 576
  • [9] VALIDITY OF RETROSPECTIVE DISEASE-ACTIVITY ASSESSMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ARCESALINAS, A
    CARDIEL, MH
    GUZMAN, J
    ALCOCERVARELA, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 417 - 417
  • [10] THE RELATIONSHIP OF ANTICARDIOLIPIN ANTIBODIES TO DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    COOPER, RC
    KLEMP, P
    STIPP, CJ
    BRINK, S
    BRITISH JOURNAL OF RHEUMATOLOGY, 1989, 28 (05): : 379 - 382